X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Bristol-Myers Squibb Co. and Sanofi-Aventis SA said Monday they filed an injunction against Apotex Corp. to stop the Canadian drug maker from selling a less expensive, generic version of the blood thinner Plavix. They also said they have begun discounting Plavix to stem the loss of the drug’s market share.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 3 articles* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?

 
 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.